{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:15:51Z","timestamp":1777493751577,"version":"3.51.4"},"reference-count":24,"publisher":"SAGE Publications","issue":"8","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Child and Adolescent Psychopharmacology"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>(1) To examine adherence of universal screening for adolescent depression at initial visits by using an established screening instrument (Patient Health Questionnaire 9 [PHQ-9]) in a university-affiliated urban developmental center that serves children with developmental disabilities (DDs); (2) to study the frequency of positive screening for depression in adolescents with DD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Review of all adolescents referred for multidisciplinary evaluation in a developmental center in 2019. Data included demographics, DD diagnoses, and use of and scores on the PHQ-9 at initial visit. Statistics included chi-square and non-parametrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of all the children evaluated in 2019 (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      \u2009=\u2009240), 52 were adolescents, 35 boys (63%)\/17 girls (37%), age 14\u2009\u00b1\u20092 years old, and 27 (54%) belonging to a bilingual English\u2013Spanish household. DD: Developmental Language Disorder (88%), Learning Disabilities (54%), attention-deficit\/hyperactivity disorder (44%), Autism Spectrum Disorder (25%), Intellectual Disabilities (12%), and Phonological Disorder (8%). The PHQ-9 was administered to 30 (58%) individuals. Scores varied from minimal depression for 17 (57%), mild for 10 (33%), and moderate and severe for 3 (10%); 3 patients endorsed suicidality. Females were more likely to obtain higher scores on the PHQ-9 than males. Adolescents diagnosed with Autism Spectrum Disorder, Intellectual Disabilities, and Phonological Disorder were less likely to be screened.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>More than half of the sample of urban adolescents with DD were screened for depression at initial visit, and 10% screened positive for moderate to severe depression. Efforts to follow the U.S. Preventive Services Task Force recommendation of universal screening of adolescent depression should continue. However, given challenges with reading and verbal abilities, screening modifications (reading to them) should be considered.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/cap.2021.0062","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T17:10:03Z","timestamp":1632849003000},"page":"572-576","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Screening for Depression in Adolescents with Developmental Disabilities: Brief Report"],"prefix":"10.1177","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6606-5948","authenticated-orcid":false,"given":"Maria","family":"Valicenti-McDermott","sequence":"first","affiliation":[{"name":"RFK Children's Evaluation and Rehabilitation Center, Children's Hospital at Montefiore, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Rivelis","sequence":"additional","affiliation":[{"name":"RFK Children's Evaluation and Rehabilitation Center, Children's Hospital at Montefiore, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Bernstein","sequence":"additional","affiliation":[{"name":"RFK Children's Evaluation and Rehabilitation Center, Children's Hospital at Montefiore, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Joanne","family":"Cardin","sequence":"additional","affiliation":[{"name":"RFK Children's Evaluation and Rehabilitation Center, Children's Hospital at Montefiore, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Seijo","sequence":"additional","affiliation":[{"name":"RFK Children's Evaluation and Rehabilitation Center, Children's Hospital at Montefiore, Bronx, New York, USA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders 5th ed Text Revised. Washington DC: American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedn.2017.10.001"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1922"},{"key":"e_1_3_2_5_1","unstructured":"Centers for Disease Control and Prevention National Center for Health Statistics: Underlying Cause of Death 1999\u20132019 on CDC WONDER Online Database. 2020. Available at: http:\/\/wonder.cdc.gov\/ucd-icd10.html (accessed January21 2021)."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.31887\/DCNS.2015.17.2\/tchandrasekhar"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1370\/afm.1854"},{"key":"e_1_3_2_8_1","unstructured":"CMS Center for Clinical Standards & Quality: Summary of Representative Clinical Depression Screening Tools. 2015. Available at: https:\/\/www.cms.gov\/Medicare\/Quality-Initiatives-Patient-Assessment-Instruments\/ESRDQIP\/Downloads\/Summary-of-Representative-Clinical-Depression-Screening-Tools.pdf (accessed January21 2021)."},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2014.12.004"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/DBP.0000000000000750"},{"key":"e_1_3_2_11_1","first-page":"177","article-title":"Accessibility in questionnaire research: Integrating universal design to increase the participation of individuals with learning disabilities","volume":"16","author":"Goegan A","year":"2018","unstructured":"Goegan A, , Daniels RL: Accessibility in questionnaire research: Integrating universal design to increase the participation of individuals with learning disabilities. Learn Disabilities Contemp J, 16:177\u2013190, 2018.","journal-title":"Learn Disabilities Contemp J"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10802-018-0402-1"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10803-012-1679-5"},{"key":"e_1_3_2_14_1","article-title":"Association of race and ethnicity with comorbidities and survival among patients with COVID-19 at an Urban Medical Center in New York","volume":"1","author":"Kabarriti R","year":"2020","unstructured":"Kabarriti R, , Brodin NP, , Maron MI, , Guha C, , Kalnicki S, , Garg MK, , Racine AD: Association of race and ethnicity with comorbidities and survival among patients with COVID-19 at an Urban Medical Center in New York. JAMA Netw Open, 1;3:e2019795, 2020.","journal-title":"JAMA Netw Open"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.3928\/0048-5713-20020901-06"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201400465"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rasd.2010.06.012"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0144.x"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0852"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000102"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjquality.u209517.w3913"},{"key":"e_1_3_2_23_1","unstructured":"Suicide Assessment Five-Step Evaluation and Triage (SAFE-T) Substance Abuse and Mental Health Services Administration. 2009. Available at: https:\/\/store.samhsa.gov\/sites\/default\/files\/d7\/priv\/sma09-4432.pdf (accessed May7 2021)."},{"key":"e_1_3_2_24_1","unstructured":"U.S. Preventive Services Task Force: Screening and treatment for major depressive disorder in children and adolescents. 2009. Available at: www.uspreventiveservicestaskforce.org\/uspstf09\/depression (accessed December10 2020)."},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.acap.2013.11.006"}],"container-title":["Journal of Child and Adolescent Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/cap.2021.0062","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2021.0062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/cap.2021.0062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:56:13Z","timestamp":1777388173000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/cap.2021.0062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["10.1089\/cap.2021.0062"],"URL":"https:\/\/doi.org\/10.1089\/cap.2021.0062","relation":{},"ISSN":["1044-5463","1557-8992"],"issn-type":[{"value":"1044-5463","type":"print"},{"value":"1557-8992","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}